Healthcare AI adoption accelerates as 70% of providers scale GenAI
ILLINOIS, UNITED STATES — Healthcare organizations are rapidly embracing artificial intelligence (AI) to transform operations and patient care, with 70% of payers and providers now deploying generative AI at scale.
A report from Bessemer Venture Partners, Amazon Web Services, and Bain & Company reveals that AI adoption is accelerating beyond pilot phases, driven by investments in clinical support, administrative efficiency, and drug discovery.
AI adoption surges in clinical and administrative functions
Healthcare providers are increasingly integrating AI into both administrative workflows and clinical decision-making.
The Healthcare AI Adoption Index of Bessemer Venture Partners shows that most industries use AI for administrative tasks such as medical coding and billing, and appointment and eligibility processes at 58%, while 44% of the industries utilize AI in clinical support and imaging for analysis.
Such a change puts into focus the two basic roles of reducing operational costs and the use of AI in enhancing the accuracy of patient care.
Early adopters like Chicago’s Rush health system report tangible benefits, including a 74% drop in clinician burnout after deploying ambient AI.
Similarly, India’s Manipal Hospitals reduced pharmacy order times to under five minutes using Google’s GenAI, demonstrating AI’s potential to streamline workflows.
Biopharma and regulatory progress drive AI expansion
Biopharma companies are leading AI adoption in research, with 74% already applying AI to drug discovery and clinical trial optimization.
The report notes that 60% of biopharma executives have set near-term ROI targets, signaling a focus on measurable outcomes. Regulatory support is also growing; Food and Drug Administration (FDA)-approved AI/ML medical devices have surged by 30 since 2014, indicating stronger trust in AI-driven solutions.
Despite progress, challenges like data quality, cited by 47% of leaders, and talent shortages, cited by 42%, persist.
Yet optimism remains high: 81% of executives believe AI will significantly improve patient outcomes within five years.
Strategic adopters, like those using IBM and Google’s AI for clinical data integration, are proving that enterprise-wide AI roadmaps deliver the most value.
